Two electrical engineers took a fresh approach to drug discovery, merging semiconductors with cellular biology.
Create the future
Our team excels at convening extraordinary leaders who have the vision to bring transformative technologies to market. In just the past 5 years, 100+ startups have launched to commercialize Harvard innovations, collectively raising more than $4.4 billion in equity financing.
New companies are taking shape all the time. Take an early look at our emerging Startup Opportunities and join us in building ventures that could change the world.
Harvard faculty are preeminent scholars and prolific inventors. In OTD, we also understand that some academic innovations need a boost to succeed commercially.
OTD’s pioneering technology accelerator programs—the Blavatnik Biomedical Accelerator and the Physical Sciences & Engineering Accelerator—help bridge the development gap, providing focused funding and resources to validate and de-risk promising technologies for successful partnering.
What ultimately makes it all work? Passionate people.
Our wide network of venture capitalists and entrepreneurs—many of whom are Harvard alumni—give generously of their time and expertise, leading and investing in new startup companies, engaging with labs as Entrepreneurs in Residence or Experts in Residence, serving on our accelerator advisory committees, speaking at OTD events, and making valuable connections throughout Cambridge and Boston.
Metalenz has won several 3D depth sensing designs for its metasurface optics with leading OEMs in Asia. First commercial end-product shipments from OEMs begin Q3’23.
Clean-tech startup Quino Energy launches to create grid-scale battery infrastructure for greater use of wind and solar power
A new startup, Quino Energy, aims to bring to market a grid-scale energy storage solution developed by Harvard researchers to facilitate more widespread adoption of renewable energy sources.